Biopharmaceutical protein production under controlled environments: Growth, development, and vaccine productivity of transgenic tomato plants grown hydroponically in a greenhouse

HortScience

Volumn 44, Issue 6, 2009, Pages 1594-1599

  Matsuda, Ryo ^a   Kubota, Chieri ^a   Lucrecia Alvarez, M ^b   Cardineau, Guy A ^b  

^a Environmental Research Laboratory   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Controlled environment agriculture; Edible vaccine; High value protein; Molecular farming; Plant made pharmaceuticals (PMP); Solanum lycopersicum

Indexed keywords

LYCOPERSICON ESCULENTUM; SOLANUM;

EID: 70350164752     PISSN: 00185345     EISSN: None     Source Type: Journal    
DOI: 10.21273/hortsci.44.6.1594     Document Type: Article

References (24)

1. Alvarez, M.L., H.L. Pinyerd, J.D. Crisantes, M.M. Rigano, J. Pinkhasov, A.M. Walmsley, H.S. Mason, and G.A. Cardineau. 2006. Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice. Vaccine 24:2477-2490.
2. Alvarez, M.L., H.L. Pinyerd, E. Topal, and G.A. Cardineau. 2008. P19-dependent and P19-independent reversion of F1-V gene silencing in tomato. Plant Mol. Biol. 68:61-79.
3. Cook, R. and L. Calvin. 2005. Greenhouse tomatoes change the dynamics of the North American fresh tomato industry. USDA Econ. Res. Rpt. No. 2. April 2005. .
4. Daniell, H., S.J. Streatfield, and K. Wycoff. 2001. Medical molecular farming: Production of anti-bodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6:219-226.
5. Ho, L.C. 2004. The contribution of plant physiology in greenhouse tomato soilless culture. Acta Hort. 648:19-25.
6. Huang, Z., G. Elkin, B.J. Maloney, N. Beuhner, C.J. Arntzen, Y. Thanavala, and H.S. Mason. 2005. Virus-like particle expression and assembly in plants: Hepatitis B and Norwalk viruses. Vaccine 23:1851-1858.
7. Inglesby, T.V., D.T. Dennis, D.A. Henderson, J.G. Bartlett, M.S. Ascher, E. Eitzen, A.D. Fine, A.M. Friedlander, J. Hauer, J.F. Koerner, M. Layton, J. McDade, M.T. Osterholm, T. O'Toole, G. Parker, T.M. Perl, P.K. Russell, M. Schoch-Spana, and K. Tonat. 2000. Plague asa biologicalweapon. JAMA 283:2281-2290.
8. Jani, D., L.S. Meena, Q.M. Rizwan-ul-Haq, Y. Singh, A.K. Sharma, and A.K. Tyagi. 2002. Expression of cholera toxin B subunit in transgenic tomato plants. Transgenic Res. 11:447-454.
9. Jones, J.B., Jr. 2007. Tomato plant culture. In the field, greenhouse, and home garden. 2nd Ed. CRC Press, Boca Raton, FL.
10. Kubota, C.,C.A.Thomson, M.Wu,andJ.Javanmardi. 2006. Controlled environments for production of value-added food crops with high phytochemical concentrations: Lycopene in tomato as an example. HortScience 41:522-525.
11. Lou, X.M., Q.H. Yao, Z. Zhang, R.H. Peng, A.S. Xiong, and H.K. Wang. 2007. Expression of the human B virus large surface antigen gene in transgenic tomato plants. Clin. Vaccine Immunol. 14:464-469.
12. Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
13. Mason, H.S. and C.J. Arntzen. 1995. Transgenic plants as vaccine production systems. Trends Biotechnol. 13:388-392.
14. Mason, H.S., H. Warzecha, T. Mor, and C.J. Arntzen. 2002. Edible plant vaccines: Applications for prophylactic and therapeutic molecular medicine. Trends Mol. Med. 8:324-329.
15. Peet, M.M. and G. Welles. 2005. Greenhouse tomato production, p. 257-304. In: Heuvelink, E. (ed.). Crop production science in horticulture series. Vol. 13. Tomatoes. CABI Publishing, Wallingford, UK.
16. Ramírez, Y.J.R., E. Tasciotti, A. Gutierrez-Ortega, A.J.D. Torres, M.T.O. Flores, M. Giacca, and M.A ́.G. Lim. 2007. Fruit-specific expression of the human immunodeficiency virus type 1 Tat gene in tomato plants and its immunogenic potential in mice. Clin. Vaccine Immunol. 14:685-692.
17. Sandhu, J.S., S.F. Krasnyanski, L.L. Domier, S.S. Korban, M.D. Osadjan, and D.E. Buetow. 2000. Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgenic Res. 9:127-135.
18. Stevens, G., E. Vories, M. Mulesky, M. Rhine, and D. Dunn. 2007. Irrigation to maximize vaccine antigen production in genetically modified tobacco. Agron. J. 99:1271-1277.
19. Stevens, L.H., G.M. Stoopen, I.J.W. Elbers, J.W. Molthoff, H.A.C. Bakker, A. Lommen, D. Bosch, and W. Jordi. 2000. Effect of climate conditions and plant developmental stage on the stability of antibodies expressed in transgenic tobacco. Plant Physiol. 124:173-182.
20. Sun, H.J., H. Kataoka, M. Yano, and H. Ezura. 2007. Genetically stable expression of functional miraculin, a new type of alternative sweetener, in transgenic tomato plants. Plant Biotechnol. J. 5:768-777.
21. Thanavala, Y., Z. Huang, and H.S. Mason. 2006. Plant-derived vaccines: A look back at the highlights and a view to the challenges on the road ahead. Expert Rev. Vaccines 5:249-260.
22. Twyman, R.M., E. Stoger, S. Schilliberg, P. Christou, and R. Fischer. 2003. Molecular farming in plants: Host systems and expression technology. Trends Biotechnol. 21:570-578.
23. Wu, M. and C. Kubota. 2008. Effects of high electrical conductivity of nutrient solution and its application timing on lycopene, chlorophyll and sugar concentrations of hydroponic tomatoes during ripening. Scientia Hort. 116:122-129.
24. Zhang, X., N.A. Buehner, A.M. Hutson, M.K. Estes, and H.S. Mason. 2006. Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol. J. 4:419-432.